ADAPTIN BIO, INC.

ADAPTIN BIO, INC. (ticker: APTN) is an OTC-listed biological products, (no diagnostic substances) company. DredgeCap's structured extraction of APTN's SEC filings surfaces 3 active risk signals, including 2 late-filing signals, and 1 auditor-change signal. APTN reported no tagged revenue in revenue and -$5.17M for the period ending 2025-12-31, with operating cash flow of -$4.78M. Cash and equivalents stood at $459K (up 1247.1% year-over-year). Total assets of $619K are exceeded by total liabilities of $2.11M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.